FDA Commissioner Scott Gottlieb announced a framework to help assure product quality and transparency at foreign drug manufacturing facilities, which includes a recently updated inspections classifications database, and a new MAPP used by CDER staff to prioritize manufacturing sites for routine inspections.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
